Analysts See 39% Upside in Hinge Health as EPS Estimates Climb 63%
Shares of Hinge Health have gained 0.4% over the past four weeks to $41.92, while analysts’ mean price target of $58.25 implies a 39% upside. The 16 short-term targets carry a $6.92 standard deviation and consensus EPS forecasts for the year have jumped 63.2%.
1. Current Price and Consensus Upside
Shares of Hinge Health have gained 0.4% over the last four weeks to close at $41.92. The mean of 16 analysts' price targets stands at $58.25, implying a 39% potential increase from the current level.
2. Target Range and Analyst Agreement
Price targets range from $48.00 to $72.00, representing upsides of 14.5% to 71.8%. The $6.92 standard deviation highlights moderate dispersion, indicating analysts largely concur on the stock’s trajectory but differ on magnitude.
3. EPS Revisions Strengthen Outlook
Consensus EPS forecasts for the current fiscal year have been revised higher by 63.2% as four estimates moved up with no downgrades. This upward revision trend supports the bullish case for near-term price appreciation.
4. Investor Considerations
While clustered targets and EPS upgrades offer compelling signals, price targets can be biased by business incentives. Investors should weigh these metrics alongside fundamentals and risk tolerance before making decisions.